Norges Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-577,785
| Closed | -$95.5M | – | 2393 |
|
|
2021
Q2 | $95.5M | Sell |
577,785
-11,478
| -2% | -$1.92M | 0.02% | 668 |
|
|
2021
Q1 | $90.4M | Buy |
589,263
+9,890
| +2% | +$1.34M | 0.02% | 679 |
|
|
2020
Q4 | $72.7M | Buy |
579,373
+10,807
| +2% | +$1.21M | 0.02% | 747 |
|
|
2020
Q3 | $57.7M | Sell |
568,566
-46,635
| -8% | -$4.75M | 0.02% | 767 |
|
|
2020
Q2 | $59.9M | Sell |
615,201
-37,027
| -6% | -$3.45M | 0.02% | 727 |
|
|
2020
Q1 | $54.2M | Buy |
652,228
+18,148
| +3% | +$1.77M | 0.02% | 664 |
|
|
2019
Q4 | $70.5M | Buy |
634,080
+18,384
| +3% | +$1.89M | 0.02% | 705 |
|
|
2019
Q3 | $61.1M | Buy |
615,696
+56,738
| +10% | +$5.63M | 0.02% | 751 |
|
|
2019
Q2 | $55.4M | Sell |
558,958
-1,175
| -0.2% | -$112K | 0.02% | 808 |
|
|
2019
Q1 | $61.8M | Sell |
560,133
-18,683
| -3% | -$1.95M | 0.02% | 729 |
|
|
2018
Q4 | $53.2M | Hold |
578,816
| – | – | 0.02% | 712 |
|
|
2018
Q3 | $63.8M | Buy |
578,816
+37,779
| +7% | +$3.93M | 0.02% | 697 |
|
|
2018
Q2 | $50.5M | Sell |
541,037
-142,394
| -21% | -$12.3M | 0.02% | 825 |
|
|
2018
Q1 | $56.7M | Buy |
683,431
+83,555
| +14% | +$7.42M | 0.02% | 723 |
|
|
2017
Q4 | $54.6M | Sell |
599,876
-13,338
| -2% | -$1.11M | 0.02% | 749 |
|
|
2017
Q3 | $46.7M | Buy |
613,214
+49,017
| +9% | +$3.7M | 0.02% | 822 |
|
|
2017
Q2 | $42.3M | Buy |
564,197
+70,147
| +14% | +$4.86M | 0.02% | 856 |
|
|
2017
Q1 | $32.2M | Sell |
494,050
-274,119
| -36% | -$16.1M | 0.01% | 1027 |
|
|
2016
Q4 | $42.3M | Buy |
768,169
+345,000
| +82% | +$18.9M | 0.02% | 763 |
|
|
2016
Q3 | $22.8M | Hold |
423,169
| – | – | 0.01% | 1142 |
|
|
2016
Q2 | $17.7M | Buy |
423,169
+69,390
| +20% | +$3.2M | 0.01% | 1277 |
|
|
2016
Q1 | $15.1M | Buy |
353,779
+201,642
| +133% | +$8.52M | 0.01% | 1331 |
|
|
2015
Q4 | $6.89M | Buy |
152,137
+127,597
| +520% | +$5.36M | ﹤0.01% | 1778 |
|
|
2015
Q3 | $953K | Buy |
+24,540
| New | +$983K | ﹤0.01% | 2120 |
|
Other funds holding PRAH
Norges Bank's PRAH Position: Q3 2021 in Review
Norges Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 577,785 shares — an estimated $95.5M sold.
Norges Bank first reported a position in PRAH in Q3 2015 and held it in 24 quarters. The position peaked at $95.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Norges Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Norges Bank sold 577,785 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $95.5M.
- Norges Bank first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 24 quarters.
- Norges Bank's PRA Health Sciences, Inc. position peaked at $95.5M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Norges Bank's 13F filing for Q3 2021, filed 5 Nov 2021.